+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Phosphorodiamidate Morpholino Oligomers Market - Global Forecast 2025-2030- Product Image
Phosphorodiamidate Morpholino Oligomers Market - Global Forecast 2025-2030- Product Image
Sale

Phosphorodiamidate Morpholino Oligomers Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6120182
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Phosphorodiamidate morpholino oligomers are advancing targeted gene modulation by addressing previously undruggable conditions and enabling new frontiers in precision medicine. Senior industry leaders are seeking actionable insights amid evolving regulatory, supply chain, and competitive dynamics shaping the future of antisense therapeutics.

Market Snapshot: Phosphorodiamidate Morpholino Oligomer Industry

The phosphorodiamidate morpholino oligomer market is experiencing notable growth, catalyzed by demand for precision therapeutic platforms and ongoing innovation in gene targeting technology. Recent advancements in delivery modalities and increased collaboration between academia and industry have resulted in greater clinical adoption. Expansion of regulatory frameworks and evolving supply chain solutions are further supporting market momentum. Concurrently, the Americas, EMEA, and Asia-Pacific regions are contributing to a robust pipeline of clinical candidates and manufacturing capabilities.

Scope & Segmentation

This report comprehensively assesses the phosphorodiamidate morpholino oligomer market, analyzing technology adoption, application dynamics, and regional developments. Market segmentation focuses on the following areas:

  • Application: Genetic disorders (including DMD exon skipping and spinal muscular atrophy), infectious diseases (bacterial and viral), and oncology (such as breast and lung cancer).
  • Delivery Modality: Lipid- and peptide-conjugated morpholinos (cholesterol, docosanyl, penetratin, Tat), and unconjugated formats.
  • End User: Contract research organizations, hospitals and clinics, pharmaceutical and biotech enterprises, and research institutes.
  • Formulation: Liquid preparations and lyophilized powders.
  • Distribution Channel: Direct sales, distributor partnerships, and online channels.
  • Geography: Americas (United States, Canada, Mexico, Brazil, Argentina), EMEA (including United Kingdom, Germany, France, Russia, and emerging markets in the Middle East and Africa), and Asia-Pacific (China, India, Japan, Australia, South Korea, ASEAN countries).
  • Companies Profiled: Sarepta Therapeutics, Inc., Gene Tools, LLC, Thermo Fisher Scientific Inc., TriLink BioTechnologies, LLC, Biomers.net GmbH, GeneDesign, Inc., Phio Pharmaceuticals Corp., Eton Bioscience, Inc., Gene Link, Inc., GenScript Biotech Corporation.

Key Takeaways

  • Novel delivery and conjugation strategies are transitioning morpholino oligomers from preclinical proof-of-concept to clinical implementation.
  • Collaborations between pharmaceutical companies and biotech startups are accelerating translational research and expanding therapeutic pipelines.
  • Regulatory frameworks for nucleic acid therapeutics are offering more defined pathways for approval, supporting efficient timelines for product development.
  • Integration of advanced analytics, machine learning, and bioinformatics is optimizing sequence design and reducing experimental burden in early-stage development.
  • Supply chain resilience is a growing strategic imperative, with industry stakeholders adopting digital traceability and domestic production capabilities.
  • Competitive positioning increasingly relies on differentiated proprietary platforms, robust IP management, and strategic partnerships with key research institutions.

Tariff Impact on Supply Chains and Commercial Strategy

The introduction of updated United States tariff measures in 2025 has raised procurement costs for key precursors and reagents, influencing global sourcing strategies for phosphorodiamidate morpholino oligomers. Industry leaders are proactively diversifying suppliers, investing in domestic manufacturing, and renegotiating terms with downstream partners to mitigate risk. Flexible contracts and heightened collaboration with contract organizations are central to adjusting for duty changes. Digital logistics solutions are being adopted to increase visibility and resilience across the supply chain.

Methodology & Data Sources

The research framework combines in-depth interviews with industry experts, secondary validation from peer-reviewed literature, regulatory filings, and conference proceedings. Quantitative models analyze clinical pipelines, patent activity, and scenario outcomes to correlate technology trends and operational dynamics across key segments.

Why This Report Matters

  • Empowers leadership to make informed decisions by providing a market-wide, integrated analysis focused on technologies and geographies currently redefining therapeutic standards.
  • Equips stakeholders to proactively address regulatory shifts, supply chain complexities, and new investment imperatives connected to phosphorodiamidate morpholino oligomers.
  • Informs strategic planning by mapping segment nuances, competitor actions, and innovation benchmarks, supporting differentiated market positioning.

Conclusion

Through detailed segmentation and targeted analysis, this report serves as a critical resource for leaders navigating the evolving phosphorodiamidate morpholino oligomer landscape. Organizations can leverage these insights to align strategy, accelerate development, and enhance patient impact.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of PMO-based antisense therapies targeting Duchenne muscular dystrophy with improved delivery platforms
5.2. Adoption of nanoparticle and lipid conjugation strategies to enhance PMO cellular uptake and tissue specificity
5.3. Rising venture capital funding and licensing deals fueling PMO patent portfolio expansions in rare diseases
5.4. Regulatory momentum behind PMO orphan drug designations accelerating spinal muscular atrophy approvals
5.5. Development of oral and inhaled PMO formulations to enable noninvasive administration across diverse patient populations
5.6. Integration of PMO scaffolds with CRISPR and other gene editing tools for precise modulation in preclinical models
5.7. Emergence of multi-exon skipping PMO cocktails addressing heterogeneous mutation profiles in neuromuscular disorders
5.8. Implementation of continuous flow chemistry and automated processes to drive down large-scale PMO manufacturing costs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Phosphorodiamidate Morpholino Oligomers Market, by Application
8.1. Introduction
8.2. Genetic Disorders
8.2.1. Dmd
8.2.1.1. Exon Skipping
8.2.2. Sma
8.3. Infectious Diseases
8.3.1. Bacterial Infections
8.3.2. Viral Infections
8.4. Oncology
8.4.1. Breast Cancer
8.4.2. Lung Cancer
9. Phosphorodiamidate Morpholino Oligomers Market, by Delivery Modality
9.1. Introduction
9.2. Lipid Conjugated
9.2.1. Cholesterol
9.2.2. Docosanyl
9.3. Peptide Conjugated
9.3.1. Penetratin
9.3.2. Tat
9.4. Unconjugated
10. Phosphorodiamidate Morpholino Oligomers Market, by End User
10.1. Introduction
10.2. Contract Research Organizations
10.3. Hospitals and Clinics
10.4. Pharmaceuticals and Biotech Companies
10.5. Research Institutes
11. Phosphorodiamidate Morpholino Oligomers Market, by Formulation
11.1. Introduction
11.2. Liquid
11.3. Lyophilized Powder
12. Phosphorodiamidate Morpholino Oligomers Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online
13. Americas Phosphorodiamidate Morpholino Oligomers Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Phosphorodiamidate Morpholino Oligomers Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Phosphorodiamidate Morpholino Oligomers Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Sarepta Therapeutics, Inc.
16.3.2. Gene Tools, LLC
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. TriLink BioTechnologies, LLC
16.3.5. Biomers.net GmbH
16.3.6. GeneDesign, Inc.
16.3.7. Phio Pharmaceuticals Corp.
16.3.8. Eton Bioscience, Inc.
16.3.9. Gene Link, Inc.
16.3.10. GenScript Biotech Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET: RESEARCHAI
FIGURE 26. PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET: RESEARCHSTATISTICS
FIGURE 27. PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET: RESEARCHCONTACTS
FIGURE 28. PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY EXON SKIPPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY EXON SKIPPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY SMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY SMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY CHOLESTEROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY CHOLESTEROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DOCOSANYL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DOCOSANYL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PENETRATIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PENETRATIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY TAT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY TAT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY UNCONJUGATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY UNCONJUGATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PHARMACEUTICALS AND BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PHARMACEUTICALS AND BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 134. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 135. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2018-2024 (USD MILLION)
TABLE 136. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2025-2030 (USD MILLION)
TABLE 137. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 138. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 139. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 140. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 141. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2024 (USD MILLION)
TABLE 142. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2025-2030 (USD MILLION)
TABLE 143. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2024 (USD MILLION)
TABLE 144. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2025-2030 (USD MILLION)
TABLE 145. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2024 (USD MILLION)
TABLE 146. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2025-2030 (USD MILLION)
TABLE 147. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 150. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 151. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. CANADA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2018-2024 (USD MILLION)
TABLE 158. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2025-2030 (USD MILLION)
TABLE 159. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 160. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 161. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 163. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2024 (USD MILLION)
TABLE 166. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2025-2030 (USD MILLION)
TABLE 167. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2024 (USD MILLION)
TABLE 168. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2025-2030 (USD MILLION)
TABLE 169. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 172. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 173. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. MEXICO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. GERMANY PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. GERMANY PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. GERMANY PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 268. GERMANY PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 269. GERMANY PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2018-2024 (USD MILLION)
TABLE 270. GERMANY PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, 2025-2030 (USD MILLION)
TABLE 271. GERMANY PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 272. GERMANY PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 273. GERMANY PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 274. GERMANY PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 275. GERMANY PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2024 (USD MILLION)
TABLE 276. GERMANY PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2025-2030 (USD MILLION)
TABLE 277. GERMANY PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2024 (USD MILLION)
TABLE 278. GERMANY PHOSPHORODIAMIDATE MORPHOLINO OL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Phosphorodiamidate Morpholino Oligomers market report include:
  • Sarepta Therapeutics, Inc.
  • Gene Tools, LLC
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies, LLC
  • Biomers.net GmbH
  • GeneDesign, Inc.
  • Phio Pharmaceuticals Corp.
  • Eton Bioscience, Inc.
  • Gene Link, Inc.
  • GenScript Biotech Corporation

Related Reports

Duchenne Muscular Dystrophy Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Duchenne Muscular Dystrophy Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 115 Pages
  • Global
From
Cell Penetrating Peptide -PMO Conjugate Market - Global Forecast 2025-2030 - Product Image

Cell Penetrating Peptide -PMO Conjugate Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
PMO Drug Market - Global Forecast 2025-2030 - Product Image

PMO Drug Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Duchenne Muscular Dystrophy Drugs Global Market Report 2025 - Product Image

Duchenne Muscular Dystrophy Drugs Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
(4-Aminophenyl)(Morpholino)-Methanone (CAS 51207-86-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

(4-Aminophenyl)(Morpholino)-Methanone (CAS 51207-86-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.